| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-27 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.89B | $1.65B | $2.08B |
| YoY Revenue Growth % | +14.5% | -20.4% | — |
| Gross Profit | $904.0M | $741.0M | — |
| Gross Margin % | 47.7% | 44.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$440.0M | -$3.23B | -$33.0M |
| Operating Margin % | -23.2% | -195.0% | -1.6% |
| Net Income (GAAP) | -$392.0M | -$3.09B | -$27.0M |
| EBITDA (Normalized) | -$376.8M | -$3.16B | $41.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $602.0M | $400.0M | $394.0M |
| Capital Expenditures (CapEx) | $79.0M | $81.0M | $93.6M |
| Free Cash Flow (FCF) | $523.0M | $319.0M | $300.4M |
| FCF Margin % | 27.6% | 19.3% | 14.5% |
| Return on Invested Capital (ROIC %) | -3.4% | -23.4% | -1.4% |
| Cash & Short-Term Equivalents | $1.84B | $1.43B | — |
| Total Debt (Short + Long Term) | $274.9M | $221.4M | $701.4M |
| Total Stockholders' Equity | $11.88B | $12.09B | $1.44B |